In such a follow-up study, additional inflammation parameters to CRP, such as TNF-α, IFN-γ, and/or IL-1, should be included to gain more insight into the potential mechanistic links between complement activation and pro-inflammatory processes in patients with cancer cachexia. This evidence concerns the gene IFNG and cancer.